Express Scripts 2015 Annual Report Download - page 5

Download and view the complete annual report

Please find page 5 of the 2015 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

• We introduced the industry’s first indication-based
formulary, making sure that clients do not pay the
same amount for a drug that works less well in
certain cancers where the drug has proven to be
less efficacious.
When we lead, we provide value to shareholders.
We delivered strong financial performance in 2015,
achieving a record 97% retention rate and growing our
adjusted earnings per share by 13%1. We were prudent
and disciplined with our cash, returning value to
shareholders through a $5.5 billion accelerated
share buyback. We are also on our game from an
operational perspective.
Even though our 1/1/2016 was the
most complex rollout we ever executed
on, we delivered the best service
levels in our history.
With more than twice as many lives as last year to
implement, and thousands of benefits changes for
existing clients, we clearly demonstrated that we are
serving our clients better and more effectively than ever.
Our financial and operational performance last year
underscores the fact that our formula for success is
straightforward: when we deliver excellence, we earn
the right to serve more people. When we do that, our
business grows.
On May 5, immediately following our annual
shareholder meeting, I will officially become CEO of
Express Scripts. I am excited, and humbled, to lead
us forward. The foundation that George Paz created is
strong and gives us something to build upon for many
years to come.
As I look ahead to where our industry is going and how
our healthcare environment is evolving, our growth
will accelerate through the unique combination of our
core PBM capabilities and supply chain management
expertise; the specialized care offered by Accredo;
the digital and high-touch member experience
delivered by our home delivery pharmacy; and the
diverse opportunities within UBC and our pharma
services business.
For 30 years, Express Scripts has successfully
helped clients and patients tackle great challenges
in healthcare by doing two things incredibly well:
controlling client costs and taking care of patients.
We plan to do that for the next 30 years too.
To better understand the value of Express Scripts, all
you need to do is understand what we do for John Day.
When you invest in us, you’re investing in John. Thank
you for giving us such an extraordinary opportunity to
help people.
Sincerely,
Tim Wentworth
President
Express Scripts Holding Company
1Excludes certain costs, including amortization expense of $1.55 per diluted
share, transaction and integration costs of $0.47 per diluted share, a legal
settlement of $0.05 per diluted share, debt redemption costs of $0.01 per
diluted share and discrete tax items of ($0.11) per diluted share.
George Paz
Chairman and Chief Executive
Officer
Timothy Wentworth
President
Eric Slusser
Executive Vice President
and Chief Financial Officer
Martin Akins
Senior Vice President, General
Counsel and Corporate Secretary
Phyllis Anderson
Senior Vice President
and Chief Marketing Officer
Don Fotsch
Senior Vice President,
Home Delivery and
Member Experience
Christine Houston
Senior Vice President,
Operations
Steven Miller, MD
Senior Vice President
and Chief Medical Officer
Everett Neville
Senior Vice President,
Supply Chain
David Queller
Senior Vice President,
Sales and Account Management
Neal Sample
Senior Vice President and
Chief Information Officer
Glen Stettin, MD
Senior Vice President, Clincal
Research and New Solutions
and Chief Innovation Officer
Sara Wade
Senior Vice President and
Chief Human Resources Officer
Management Team
Express Scripts 2015 Annual Report
3